FOUNDATION FOR BIOMEDICAL RESARCH AND INNOVATION AT KOBE.

Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.